Quantitative CT for the assessment of disease severity in interstitial lung disease

D. Parr (Coventry (West Midlands), United Kingdom), E. Helm (Coventry (West Midlands), United Kingdom), J. Shakespeare (Coventry (West Midlands), United Kingdom), R. Hughes (Coventry (West Midlands), United Kingdom), A. Bhalerao (Warwick, United Kingdom)

Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Session: What is hot in idiopathic pulmonary fibrosis?
Session type: E-poster session
Number: 1799
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Parr (Coventry (West Midlands), United Kingdom), E. Helm (Coventry (West Midlands), United Kingdom), J. Shakespeare (Coventry (West Midlands), United Kingdom), R. Hughes (Coventry (West Midlands), United Kingdom), A. Bhalerao (Warwick, United Kingdom). Quantitative CT for the assessment of disease severity in interstitial lung disease. 1799

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Quantitative assessment of lung pathology in interstitial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 243s
Year: 2001

CT and interstitial lung disease
Source: International Congress 2018 – PG4 Imaging of the chest
Year: 2018


Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019


Quantitative analysis of pulmonary cysts and emphysema on computed tomography: Lymphangioleiomyomatosis, Birt-Hogg-Dubé syndrome and chronic obstructive lung disease
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

Quantitative computed tomography imaging in asthma and chronic obstructive pulmonary disease.
Source: International Congress 2018 – Imaging biomarkers and quantitative imaging
Year: 2018


Ultra-low dose CT in the assessment of diffuse lung disease: Comparison with conventional images
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013


The effect of emphysema in patients with idiopathic pulmonary fibrosis; evaluation using quantitative CT analysis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016


Relationship between progression of disease on longitudinal high-resolution CT scans and progression of functional impairment in asbestosis
Source: Annual Congress 2007 - The air we breathe at home and at work
Year: 2007


Correlation of high resolution computed tomography (HRCT) findings with disease severity in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Imaging modalities in asthma, COPD and emphysema
Year: 2007


Assessment of disease severity using imaging scores in pulmonary sarcoidosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012


Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014

Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent
Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019
Year: 2020



Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease
Source: ERJ Open Res, 8 (1) 00549-2021; 10.1183/23120541.00549-2021
Year: 2022



The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017


Factors influencing the decline in lung density in a Danish lung cancer screening cohort
Source: Eur Respir J 2012; 40: 1142-1148
Year: 2012



Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Quantitative CT characterisation of stable COPD patients relates to COPD severity and exacerbation frequency
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006


A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


Use of MRI for functional and structural assessment of interstitial lung disease
Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease
Year: 2018